An official document containing policies and pledges for customers of Oracle’s cloud services reveals that many aspects fall in line with industry standards, while others may prompt cause for worry among customers, according to ...
Tags: Official Document, Oracle's Cloud
The US Patent and Trademark Office (USPTO) has granted a notice of allowance (NOA) to Echo Therapeutics' claimed application for its Prelude SkinPrep system and Symphony tCGM system. The claimed Patent Application No. 10/792,862 entitled ...
Tags: USPTO, NOA, application, notice of allowance, Prelude SkinPrep system
The US Patent and Trademark Office (USPTO) has granted patent No. 8,167,837 to Unilife's ready-to-fill (prefilled) syringe. The barrel of prefilled syringe utilizes the company's proprietary technology for the integration of automatic and ...
Tags: USPTO, ready-to-fill syringe, Unilife, prefilled syringe
AMTAC Certification Services has granted CE mark for CellAegis Devices's autoRIC device. The CE mark allows CellAegis to sell autoRIC Device to 32 member countries and seven cooperating countries of the european economic area, under ...
Tags: AMTAC, CE Mark, medical device
CellAegis Devices has obtained Health Canada's investigational testing (ITA) approval to initiate a pilot clinical trial of its noninvasive autoRIC device for remote ischemic conditioning (RIC). The CE-marked device is placed around ...
Tags: Health Canada, ITA, clinical trial, RIC
Thermedical has obtained 510(k) clearance for its radiofrequency-based thermal ablation system, designed for treating large volumes of solid tumors, from the US Food and Drug Administration (FDA). Featuring a single or more needles, the ...
Tags: Thermedical, thermal ablation system, FDA, radiofrequency waves, approval
Abiomed has received US Food and Drug Administration's (FDA) investigational device exemption (IDE) to begin a pivotal clinical study of its Impella Right-side Percutaneous (RP ) pump. The percutaneous heart pump is implanted through a ...
Tags: percutaneous heart pump, Impella Right-side Percutaneous pump, FDA
The US Food and Drug Administration (FDA) has granted investigational device exemption (IDE) to STENTYS to conduct a pivotal APPOSITION V clinical study for its Self-Apposing stent. The Self-Apposing technology, which adapts vessels with ...
An executive order issued by the White House last Friday seeks to bolster the government's ability to keep its emergency communications capabilities intact during national emergencies. But one privacy advocacy group expressed concern that ...
Tags: White House, Emergency Communications Riles Privacy Group
Quick-Med Technologies, a life sciences company, has received an approval from the patent office of Mexico, Instituto Mexicano de la Propiedad Industrial (IMPI), for its new patent that expands the international intellectual property ...
Tags: Quick-Med Technologies, Nimbus, IMPI
The Office of the Chief Scientist (OCS) in Israel has awarded $3m NIS grant to support BrainStorm Cell Therapeutics' research and development program for stem cell therapy candidate, NurOwn. NurOwn is an autologous, adult stem cell ...
Tags: stem cell therapy technology, Cell Therapeutics, therapy technology
China Knowledge reported that China Securities Regulatory Commission the country's stock market watchdog, has said that it had granted licenses under the Qualified Foreign Institutional Investors scheme to 9 foreign investors in October. ...
Tags: QFII Licenses, China Securities Regulatory Commission, QFII program
The Associated Press reported that 8 demonstrators arrested for peacefully protesting in Myanmar's largest city against a mining project have been freed on bail. Mr Aung Thein the lawyer for two of the activists arrested in the last ...
Tags: copper, copper mine, demonstrators
Eisai's Aciphex (rabreprazole sodium) has met the FDA's Written Request requirements for pediatric exclusivity in US. Having met FDA's requirement, the company has now gained an additional 6 months US market exclusivity for Aciphex, which ...
Tags: rabreprazole sodium, FDA, Aciphex, pediatric drug, GERD Drug
Specialty pharmaceutical company Cynapsus Therapeutics has received a Notice of Allowance from the US Patent and Trademark Office (USPTO) for a patent application No. 13/445,656 that covers APL-130277. Fast-acting APL-130277 is a thin ...